Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Ferinject |
| Active Ingredient: | Ferric carboxymaltose 180mg equivalent to iron 50mg |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturers: | BIPSO GmbH, Singen Baden, Germany IDT Biologika GmbH, Dessau-Rosslau, Germany |
| Product: | Oxytocin Injection BP |
| Active Ingredient: | Oxytocin 5IU/mL equivalent to 8.3 mcg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturers: | Panpharma GmbH, Trittau, Germany Haupt Pharma Livron, Livron sur Drome, France |
| Product: | Oxytocin Injection BP |
| Active Ingredient: | Oxytocin 10IU/mL equivalent to 16.6 mcg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturers: | Panpharma GmbH, Trittau, Germany Haupt Pharma Livron, Livron sur Drome, France |
Dated this 9th day of March 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).